Alignment Healthcare, Inc. Stock 12‑Month Price Target Cut to $11.21, Implies 39% Upside

Alignment Healthcare's average 12-month price target was reduced to $11.21 by analysts, down from $12.31, with a range of $8 to $17. This implies a 39% upside from the Oct. 29 closing price. The consensus rating remains 'Buy' among 16 analysts.

Original reporting
Published Oct 30, 2026, 1:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 1:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alignment Healthcare, Inc. Stock 12‑Month Price Target Cut to $11.21, Implies 39% Upside — source image
Decision brief

The 30-second read

$ALHCBearishLow
01

Why it matters

Analyst consensus remains a Buy, but the lower target suggests a more modest near‑term upside.

02

Market read

The target cut provides a modestly new data point for traders monitoring small‑cap healthcare stocks.

03

What to watch

Potential pipeline developments or partnership news not reflected in the target change.

Relevance 5/10Novelty 6/10Timing: current trading day

Background

Alignment Healthcare is a micro‑cap healthcare services company whose stock is closely watched by niche investors.

Company-level read

Ticker impact

$ALHCBearishMedium confidence
Context

Analysts cut the average 12-month price target for Alignment Healthcare to $11.21, implying 39% upside from the recent close.

Expected impact

likely downward pressure as investors reassess valuation

Evidence & confidence

The new target is lower than the prior consensus, signaling weaker outlook despite a still‑positive upside estimate.

Market effects

Minor impact on the healthcare services sector as analysts adjust expectations for a small‑cap player.

Limited to U.S. small‑cap investors.

Low

Counterpoint

The target cut may be overly cautious; the stock could still rally on upcoming data.

Key entities

  • Alignment Healthcare, Inc.

    Subject of the price‑target revision.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.